2 Groups model FDA [Two-Stage / GS Designs]

posted by hiren379 – India, 2013-08-22 16:32 (4677 d 14:04 ago) – Posting: # 11336
Views: 50,911

Hi HS

❝ Followed by:

❝ If the Group-by-treatment interaction test is not statistically significant (p ≥0.1), only the Group-by-treatment term can be dropped from the model.

❝ … provided that the group meets minimum requirements for a complete bioequivalence study.


According to the above statement, what should be the minimum requirements of the group for a complete bioequivalence study?

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
126 visitors (0 registered, 126 guests [including 28 identified bots]).
Forum time: 06:36 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5